Kenvue shareholders are cheering Monday as shares are surging ~16% in Monday trading following the announcement that Kimberly-Clark (KMB) will acquire the consumer healthcare products company for ...
Zacks Investment Research on MSN
Kenvue's Q2 earnings coming up: Here's what lies ahead of the stock
Kenvue Inc. KVUE is slated to report second-quarter 2026 results on Aug. 6, before market open. The company is likely to ...
The FDA approval grants Kenvue a three-year exclusivity period for the new OTC formulation. Credit: DC Studio / Shutterstock.com. The US Food and Drug Administration (FDA) has approved Kenvue's ...
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Kimberly-Clark has announced a planned $48.7b acquisition of Kenvue (NYSE:KVUE). The ...
Kenvue's board has inched up the quarterly dividend by 1.2%, to 21 cents from 20.75 cents, maintaining the consumer-health company's status as a royal dividend payer. The dividend increase maintains ...
Major U.S. equities indexes climbed Monday afternoon, boosted by gains in the tech sector as Nvidia announced a big ...
The Food and Drug Administration (FDA) has approved Tylenol with Naproxen, a fast-acting medication that combines Tylenol and ...
Kenvue's Tylenol with Naproxen just became the first FDA-approved pill combining acetaminophen and naproxen sodium — two pain ...
On Tuesday’s episode of CNBC’s Mad Money, Jim Cramer highlighted Kimberly-Clark Corporation (NYSE:KMB) as a defensive holding ...
Kenvue is using Resycure's digital platform to unlock batch-level traceability, transparent data, consistent quality and more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results